SCOPUS 정보 검색 플랫폼

Klinische Padiatrie

Volumn 214, Issue 4, 2002, Pages 153-156

Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - A phase-II-study

(6) Langler A a Christaras, A b Abshagen, K c Krauth, K b Hero, B d Berthold, F d

a Gemeinschaftskrankenhaus Herdecke (Germany)

b UNIVERSITY HOSPITAL DÜSSELDORF (Germany)

c UNIVERSITY HOSPITAL MÜNSTER (Germany)

d UNIVERSITY HOSPITAL OF COLOGNE (Germany)

Author keywords

Childhood tumors; Neuroblastoma; Phase II study; Topotecan

Indexed keywords

DNA TOPOISOMERASE INHIBITOR; TOPOTECAN; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER GROWTH; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; MONOTHERAPY; MULTICENTER STUDY; NEUROBLASTOMA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; SURVIVAL TIME; THROMBOCYTOPENIA; CANCER STAGING; DRUG ADMINISTRATION; EVALUATION; INFANT; MORTALITY; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; INFANT; MALE; NEOPLASM STAGING; NEOPLASMS; NEUROBLASTOMA; QUALITY OF LIFE; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; TOPOTECAN; TREATMENT OUTCOME; HUMANS;

EID: 0036629058 PISSN: 03008630 EISSN: None Source Type: Journal
DOI: 10.1055/s-2002-33175 Document Type: Article

Times cited : (36)

References (19)

1
- 0023541546
- Topoisomerases in cancer therapy
- (1987) Anticancer Drug Design , vol.2 , pp. 151-164
- Lock, R.B.¹ Ross, W.E.²

2
- 0029960812
- Eukaryotic DNA topoisomerase 1: Genome gatekeeper and it's intruders
- (1996) Semin Oncol , vol.23 , Issue.3 , pp. 3-10
- Pommier, Y.¹

3
- 7144248725
- Plant antitumor agents
- (1996) J Am Chemotherapy Soc , vol.88 , pp. 3888-3890
- Wall, M.E.¹ Wani, M.C.² Cook, C.E.³ Palmer, K.H.⁴ McPhail, A.T.⁵ Sim, G.A.⁶

4
- 0026468470
- Activity of topotecan, a new topoisomerase 1 inhibitor against tumor colony forming units in vitro
- (1992) J Natl Cancer Inst , vol.23 , pp. 1816-1819
- Burris, H.A.¹ Hanauske, A.R.² Johnson, R.K.³ Marshall, M.H.⁴ Kuhn, J.C.⁵

5
- 0028206027
- Activity of 9-dimethylaminomethyl-10-hydroxycampthotecin against pediatric and adult central nervous system tumor xenografts
- (1994) Cancer Chemother Pharmacol , vol.34 , pp. 171-174
- Friedman, H.S.¹ Houghton, P.J.² Schold, S.C.³ Keir, S.⁴ Bigner, D.D.⁵

6
- 4243661525
- Activity of 9-dimethylaminoethl-10-hydroxycamptothecin against CNS xenografts
- Abstract
- (1993) Proc Annu Meet Am Assoc Cancer Res , vol.34
- Friedman, H.S.¹ Houghton, P.J.² Schold, S.C.³ Bigner, D.D.⁴

7
- 0027324850
- Therapeutic efficacy of the topoisomerase-1-inhibitor-camptothecin against human tumor xenografts
- (1993) Cancer Res , vol.53 , pp. 2823-2829
- Houghton, P.J.¹ Ceshire, P.J.² Hallman, J.C.³ Bissery, M.C.⁴ Mathieur-Boue⁵ Haughton, J.A.⁶

8
- 0005582695
- Systemic exposure to topotecan related to antitumor response in human neuroblastoma xenografts
- (1997) Proc Am Ass Cancer Res , vol.38 , pp. 305
- Thompson, J.¹ Stewart, C.² Zamboni, W.³ Houghton, P.J.⁴

9
- 0032054147
- Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts
- (1998) J Natl Cancer Inst , vol.90 , pp. 505-511
- Zamboni, W.C.¹ Stewart, C.F.² Thompson, J.³ Santana, V.M.⁴ Cheshire, P.J.⁵ Richmond, L.B.⁶ Luo, X.⁷ Poquette, C.⁸ Houghton, J.A.⁹ Houghton, P.J.¹⁰

10
- 10244270659
- Phase I trial and pharmacokinetic and pharmacodynamics study of Topotecan using a five-day course in children with refractory solid tumors: A Pediatric Oncology Group Study
- (1996) J Pediatr Hematol Oncol , vol.18 , pp. 352-361
- Tubergen, D.G.¹ Stewart, C.F.² Pratt, C.B.³ Zamboni, W.C.⁴ Winick, N.⁵ Santana, V.M.⁶ Dryer, Z.A.⁷ Kurtzberg, J.⁸ Bell, B.⁹ Crier, H.¹⁰ Vietti, T.J.¹¹

11
- 8944222113
- Evaluation of topotecan for pediatric central nervous system tumors
- (1996) Cancer , vol.78 , pp. 527-531
- Blaney, S.M.¹ Phillips, P.C.² Packer, R.J.³ Heideman, R.L.⁴ Berg, S.L.⁵ Adamson, P.C.⁶ Allen, J.C.⁷ Sallan, S.E.⁸ Jakacki, R.I.⁹ Lange, B.J.¹⁰ Reaman, G.H.¹¹ Horowitz, M.E.¹² Poplack, D.G.¹³ Balis, F.M.¹⁴

12
- 0031939569
- Phase II trial of topotecan administered as 72 h-infusion in children with refractory solid tumors
- (1998) Clin Cancer Res , vol.4 , pp. 357-360
- Blaney, S.M.¹ Needle, M.N.² Gillespie, A.³ Sato, J.K.⁴ Reaman, G.H.⁵ Berg, S.L.⁶ Adamson, P.C.⁷ Krailo, M.D.⁸ Bleyer, W.A.⁹ Poplack, D.C.¹⁰ Balls, F.M.¹¹

13
- 0030482311
- Clinical studies of topotecan
- (1996) Ann N Y Acad Sci , vol.803 , pp. 264-271
- Broom, C.¹

14
- 0029991006
- Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia
- (1996) J Clin Oncol , vol.14 , pp. 1504-1511
- Furman, W.L.¹ Baker, S.D.² Pratt, C.B.³ Rivera, G.K.⁴ Evans, W.E.⁵ Stewart, C.F.⁶

15
- 0031759531
- Topotecan in pediatric patients with recurrent and progressive tumors
- (1998) J Pediatr Hematol Oncol , vol.20 , pp. 315-318
- Nitschke, R.¹ Parkhurst, J.² Sullivan, J.³ Harris, M.B.⁴ Bernstein, M.⁵ Bratt, C.⁶

16
- 0003280319
- Pharmacokinetically-guided use of topotecan given (daily*5)*2 in children with relapsed solid tumors
- (1997) ASCO-meeting , pp. 1839
- Santana, V.¹ Zamboni, W.² Gajjar, A.³ Pappo, A.⁴ Houghton, P.⁵ Meyer, W.⁶ Stewart, C.⁷

17
- 0003787911
- The National Cancer Institute
- (1986) Investigators handbook, a manual for participants in clinical trials of investigational agents sponsored by the Division of Cancer Tratement

18
- 0000286739
- Cyclophosphamide plus topotecan in children with recurrent or refractory solid timors: A pediatric oncology group phase II study
- Abstract
- (1999) J Pediatr Hematol Oncol , vol.21 , pp. 465
- Saylors, R.L.¹ Stine, K.C.²

19
- 0009752284
- Sequential administration of topotecan and etoposide in extensive small cell lung cancer - A phase-1-study
- Abstract
- (1998) Proc ASCO , vol.17 , pp. 1843
- Buchholz, E.¹ Manegold, C.² Drings, P.³ Mayer, U.⁴ Heuser, A.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.